Senile plaques are polymorphous P-amyloid protein deposits found in the brain in Alzheimer disease and normal aging. This .3-amyloid protein is derived from a larger precursor molecule of which neurons are the principal producers in brain. We found that amyloid precursor protein (APP)-immunoreactive neurites were involved in senile plaques and that only a subset of these neurites showed markers for the abnormal filaments characteristic ofneurofibrillary pathology. In the neocortex of nondemented individuals with senile plaques but spared of neurofibrillary pathology, dystrophic neurites in senile plaques showed only APP accumulation. In contrast, in the brains of Alzheimer patients, virtually all APP-immunoreactive neurites also showed immunoreactivity with ubiquitin, x, and phosphorylated neurofilaments. The presence of X and neurofrlament epitopes in dystrophic neurites in senile plaques was correlated with the extent of neurofibrillary pathology in the surrounding brain tissue. Accumulation of APP and the formation of neurofibrillary pathology in senile plaque neurites are therefore distinct phenomena. Our findings suggest that APP accumulation in senile plaque neurites occurs prior to X accumulation and is therefore more closely related to appearance of neuritic dystrophy.
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Senile plaques (SP) are extracellular amyloid deposits found in the brain most prominently in Alzheimer disease (AD) but also in normal aging (1) . Their 6-to 10-nm-wide filaments consist of a 39-to 42-amino acid f3-amyloid protein (f3-AP) (2) , which is derived from a much larger transmembrane amyloid precursor protein (APP) (3) (4) (5) . The morphology and size of SP are highly variable and are regionally dependent (6) . Recent studies have addressed the pathogenetic role of neurons, astrocytes, microglia, and capillaries in the development of SP (7) (8) (9) (10) (11) . Another prominent lesion of AD is the accumulation of straight and paired helical filaments in neuronal cell bodies and in neurites (12) . Studies of Down syndrome patients, who invariably develop pathology like that in AD, have shown that amyloid is probably deposited before any neurofibrillary pathology occurs (13) . The most frequent form of dystrophic neurites in AD are neuropil threads that are not confined to the SP (14) . Furthermore, neuropil threads are also found in progressive supranuclear palsy (15) and subacute sclerosing panencephalitis (16) in the absence of 8-AP deposits. Neuritic SP contain dystrophic neurites that accumulate paired helical filaments and membranous dense bodies (17) . It is not established whether these dystrophic neurites are a reactive phenomenon or if they are actually contributing to the amyloid deposit. The primary role of dystrophic neurites in producing the amyloid deposit has been questioned because r-immunoreactive dystrophic neurites are rare in diffuse-type SP, which may be the earliest stage of SP (18) . Recently, however, 'r-negative, but synaptophysin-and ubiquitin-immunoreactive, neurites have been demonstrated in preamyloid deposits (19) .
APP has been localized to cell processes that were tentatively identified as neurites in AD brains (20) (21) (22) (23) . We reported previously that APP-positive cell processes occur in the absence of M-AP deposits, in diffuse SP, as well as in fully developed f3-AP core-containing plaques (24) . These findings suggested that APP accumulation in cell processes could contribute to the deposition of f3-AP in SP.
The present study was undertaken to define the cellular origin of APP-immunostained cell processes in SP and to define their relationship to neurofibrillary pathology in AD and normal aging.
MATERIAL AND METHODS
We studied the hippocampus and the temporal and frontal cortex of 24 AD patients ( tTo whom reprint requests should be addressed.
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and three controls that had at least some SP in hippocampus and neocortex. We first immunolabeled with a rabbit antibody to APP by using the avidin-biotinylated alkaline phosphatase technique with naphthol AS-MX phosphate (Sigma) and fast red TR salt (Sigma). We photographed the sections and removed the phosphatase reaction product with ethanol and xylene. The sections were then incubated with a second antibody (to ubiquitin, T, or phNF-H) and subjected to the immunoperoxidase technique with diaminobenzidine (Sigma) as cosubstrate. This result was also photographed, so that pairs of photographs could be compared. In this way, we could study the colocalization of several antigens in the same neurites. We counted the SP neurites that were immunoreactive for APP alone and for T, ubiquitin, or phNF-H alone or together with APP. In total, we studied 106 pairs of photographs and approximately 2500 neurites in three controls and three AD patients. As a control, we reversed the order of the immunoreactions to exclude blocking of epitopes and interference with subsequent antibody binding. Characterization and absorption controls for the APP antibodies have been described (24) . The references in Table  1 contain the data on characterization of the other antibodies used in this study. RESULTS APP and 13-AP Immunostaining. All the APP antibodies directed to regions outside the 3-AP domain (anti-Bac695, anti-Bac770, RGP-3, RGP-8) recognized fine granular structures in neurons and neurites (Fig. LA) . In the subiculum of the AD patients, there were also rare pyramidal neurons (Fig.  1C ) that showed intense and homogeneous cytoplasmic immunoreactivity for APP. Some of these neurons carried NFT and many were shrunken, with their nucleus no longer detectable. In several control brains and in all the AD brains, we found small neuritic clusters and single APP-immunoreactive neurites (Fig. 1B) . By double immunostaining with APP and /8-AP antibodies, we demonstrated that some of these clusters and single neurites were surrounded by small amyloid deposits, while others were unrelated to amyloid (results not shown). In AD patients as well as in controls about one-half of the diffuse and virtually all neuritic and core-containing SP (Fig. 1D) (Table 1) . However, the latter two stained neurites less intensely.
Using antibodies directed to the /3-AP region (RGP-9, 597, and 2A1/1OB10), we found numerous SP in 24/24 (100%) of AD brains and in the hippocampus of 9/18 (50%) of the control patients. The youngest controls did not show any amyloid deposits and no abnormal neurites were found. Variable numbers of amyloid deposits were present in the neocortex of 5/16 (31%) of the controls. Of the controls over 70 years old, 8/9 (89o) showed P-AP deposits in the hippocampus and 5/8 (63%) in the temporal and frontal neocortex. In the controls, these SP were predominantly of the diffuse type, especially when present in neocortical areas.
x, Ubiquitin, and Neurofflament Immunostaining. Normal immunostaining of X (5E2) and neurofilaments (SMI-34, 1.1.1) was present in all brains: X immunolabeling consisted of a fine network of immunoreactive neurites in layers I and less in II and in subcortical white matter. Normal immunostaining for neurofilaments was present as an extensive neuritic network and also as white matter axonal staining. Ubiquitin (4.2D8) immunostaining was present in all the brains as intense labeling of SP neurites and NFT when present, diffuse vessel staining, and focally as nuclear staining. Also, corpora amylacea and small rounded corpuscles in gray and less in white matter were intensely stained.
In all the AD patients numerous r-immunoreactive neuropil threads were present in the hippocampus. They were much less numerous but were present in 9/18 (50%0o) of the control hippocampi. Also, variable numbers of NFT were Medical Sciences: Cras et al. Relationship Between APP and Cytoskeletal Markers in SP Neurites. In the hippocampus of AD patients, virtually all APP-immunoreactive SP neurites also showed X immunoreactivity (Fig. 3) . On the other hand, not all T-immunoreactive neurites were also APP-immunoreactive. In particular, many T-immunoreactive neuropil threads in the corona of SP remained unlabeled by APP antibodies. In contrast, in brains of mentally intact controls, the proportion of neurites that was APP positive and X negative was much higher (Fig. 4) . When no NFT were present in the surrounding cortex, the SP neurites showed only APP accumulation and no X positivity (Fig. 5) . The presence of X in SP neurites varied with the degree of neurofibrillary pathology. Most of the v-negative neurites in control brains also remained unlabeled with antibodies to ubiquitin or phosphorylated neurofilaments.
There were two remarkable types of abnormal neurites, both prominent in AD brains: first, swollen and solely APP-immunoreactive neurites that were not related to amyloid deposits (not shown); second, the numerous neuropil threads that were mostly X immunoreactive but APP negative (Fig. 3) .
DISCUSSION
Several important conclusions can be drawn from our study: First, by the presence of normal and altered neuronal cytoskeletal components, APP-immunoreactive cell processes could be unequivocally identified as neurites. Second, the presence of cytoskeletal alterations in APP-immunoreactive SP neurites is related to neurofibrillary pathology in the surrounding brain.
It is well established that in Down syndrome, amyloid deposits are found in a younger age group than NFT and T-immunoreactive neurites (33, 34) . A similar phenomenon occurs in a cross-sectional autopsy study that includes mentally intact elderly people and Alzheimer patients. As the incidence of AD in the control group is high, some of the control patients could have developed dementia had they lived longer. Also, mild dementia in some of the control patients could have gone unnoticed (35) . Therefore, in this population, different degrees of pathology would be expected, some corresponding to normal aged brains, others to preclinical AD, still others to fully developed Alzheimer pathology. It is reasonable to assume that these different degrees of abnormality would reflect the development of lesions in a single individual over time. At one end of this spectrum, we found that r-immunoreactive SP neurites and NFT were most prominent in AD patients and that APP-immunoreactive neurites in these cases consistently displayed X immunoreactivity. In controls, SP neurites were always APP positive, but only a small proportion were also X immunoreactive. In this group, there was a tendency for SP neurites to show T immunoreactivity, but only when NFT were present in the neurons of the same brain region. These Proc. Nati. Acad Sci. USA 88 (1991) Proc. Natl. Acad. Sci. USA 88 (1991) previous studies that showed a correlation between T-containing SP neurites and NFT (36, 37) . An important proportion of our nondemented controls showed low numbers of T-immunoreactive NFT and SP. These findings agree with the studies of Tomlinson et al. (38) (44) . In ultrastructural studies, we have found APP accumulation in similar membranous dense bodies in SP neurites (M.K., unpublished results).
It is not known whether the APP in SP neurites contributes to the extracellular amyloid deposits and if so, how the APP is released so that the ,3-AP region remains intact (45) . On the basis of previous reports and our present findings, we suggest the following pathogenetic mechanism: A neuron or neurite accumulates APP and eventually degenerates, thereby releasing APP together with numerous enzymes (46, 47) . This APP would then be locally processed, presumably by microglia, and amyloid fibers would be formed in close proximity to these cells. This amyloid protein would then exert its growth-promoting and neurotoxic activities (48, 49) on surrounding neurites that are recruited into the lesion, where these neurites would show signs of degeneration and regeneration (50) and in their turn start to accumulate APP and develop neurofibrillary pathology.
